Login / Signup

An updated systematic review and meta-analysis about the safety and efficacy of infliximab biosimilar, CT-P13, for patients with inflammatory bowel disease.

Mahmoud Ahmed EbadaAbdelmagid M ElmatbolyAhmed Said AliAhmed Mohamed IbrahimNotila FayedAhmed Faisal FaisalSouad Alkanj
Published in: International journal of colorectal disease (2019)
CT-P13 is effective and well tolerated in short and long-term periods. Switching to CT-P13 is recommended for the management of IBD.
Keyphrases
  • image quality
  • dual energy
  • computed tomography
  • contrast enhanced
  • patients with inflammatory bowel disease
  • positron emission tomography
  • magnetic resonance imaging
  • magnetic resonance
  • ulcerative colitis